Trust Wallet, a self-custodial wallet founded by Binance co-founder Changpeng “CZ” Zhao, has launched support for tokenized U ...

作者：Zen，PANews随着人工智能的快速发展，购物与支付方式正在被重塑。今年4月，Visa 推出 Visa Intelligent Commerce，借助 AI 打通“从搜索到购买”的场景，并与 Anthropic、微软、Mistral ...

Zerodha Technical Glitch has now been resolved after users faced problems with log-ins and other issues during early market ...

Kite AI raised $18 million in Series A funding led by PayPal Ventures, bringing cumulative investment to $33 million to ...

More than 55 international kite flyers from 25 countries joined local enthusiasts The skies above Sri Lanka’s capital came alive in a dazzling display of colour as the Colombo International Kite ...

AT SIX. AND NEW AT SIX. A KITESURFER RESCUED OFF GRAVES LIGHT AND A CHANCE ENCOUNTER SAVED HIS LIFE. LET’S GET TO NEWSCENTER 5 JOHN ATWATER. HE SPOKE WITH HIM. HE JOINS US LIVE FROM EAST BOSTON RIGHT ...

Analysis by GlobalData indicates that in vivo CAR-T therapies sidestep many of the drawbacks seen in ex vivo counterparts. Credit: Michael Vi via Shutterstock.com. Gilead is soaring to new heights in ...

Aug 21 (Reuters) - Gilead Sciences' (GILD.O), opens new tab unit Kite Pharma said on Thursday it will acquire privately-held biotech firm Interius BioTherapeutics for $350 million in cash to advance ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...

Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held ...

Kite, a Gilead Company, has agreed to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR therapeutics, for $350 million. This acquisition complements ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...